Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Morgan

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Critical Care Medicine|January 20, 2015
Choosing between methods to prevent methicillin-resistant Staphylococcus aureus in ICUs*Daniel J Morgan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2019
The Overton Window and a Less Dogmatic Approach to AntibioticsDaniel J Morgan
JAMA Health Forum|December 5, 2025
Public Health for the Post-COVID-19 PublicDaniel J Morgan, Deborah Korenstein
AJR. American Journal of Roentgenology|August 28, 2024
Diagnostic Stewardship: <i>AJR</i> Podcast Series on Diagnostic Excellence and Error, Episode 3Francis Deng, Daniel J Morgan
JAMA Network Open|October 17, 2019
The Important but Rarely Studied Cascade of CareJohn Mandrola, Daniel J Morgan
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2024
Special Section on Cannabinoid Signaling in Human Health and Disease-EditorialJosée Guindon, Daniel J Morgan
Primary Care|January 21, 2014
Epistaxis: evaluation and treatmentDaniel J Morgan, Rick Kellerman
Annals of Internal Medicine|May 20, 2024
Moving Beyond Central Line-Associated Bloodstream InfectionsJessica Howard-Anderson, Daniel J Morgan
Journal of Hospital Medicine|March 14, 2024
Diagnostic stewardship: Improving use of diagnostic tests for better quality and value in hospital medicineValerie M Vaughn, Daniel J Morgan
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2024
Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory DepressionJames A Carr, Daniel J Morgan
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Critical Care Medicine|January 20, 2015
Choosing between methods to prevent methicillin-resistant Staphylococcus aureus in ICUs*Daniel J Morgan
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2019
The Overton Window and a Less Dogmatic Approach to AntibioticsDaniel J Morgan
JAMA Health Forum|December 5, 2025
Public Health for the Post-COVID-19 PublicDaniel J Morgan, Deborah Korenstein
AJR. American Journal of Roentgenology|August 28, 2024
Diagnostic Stewardship: <i>AJR</i> Podcast Series on Diagnostic Excellence and Error, Episode 3Francis Deng, Daniel J Morgan
JAMA Network Open|October 17, 2019
The Important but Rarely Studied Cascade of CareJohn Mandrola, Daniel J Morgan
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2024
Special Section on Cannabinoid Signaling in Human Health and Disease-EditorialJosée Guindon, Daniel J Morgan
Primary Care|January 21, 2014
Epistaxis: evaluation and treatmentDaniel J Morgan, Rick Kellerman
Annals of Internal Medicine|May 20, 2024
Moving Beyond Central Line-Associated Bloodstream InfectionsJessica Howard-Anderson, Daniel J Morgan
Journal of Hospital Medicine|March 14, 2024
Diagnostic stewardship: Improving use of diagnostic tests for better quality and value in hospital medicineValerie M Vaughn, Daniel J Morgan
The Journal of Pharmacology and Experimental Therapeutics|September 18, 2024
Methocinnamox is a Potent and Long-Acting Antagonist that can Prevent and Reverse Opioid-Induced Respiratory DepressionJames A Carr, Daniel J Morgan
Pageof 29